BioLineRx (BLRX) Cost of Revenue (2010 - 2026)
BioLineRx's Cost of Revenue came in at $59,000 for the quarter ended Jun 30, 2026, down 18.1% from $72,000 a year earlier and down 37.9% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Cost of Revenue (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BioLineRx reported Cost of Revenue of $278,000, down 96.0% year-over-year; for the year ended Dec 31, 2025, it came in at $230,000, down 97.5% from the prior year.
- Going back by year, Cost of Revenue was $9.26 million in the year ended Dec 31, 2024 (+150.9%) and $3.69 million in the year ended Dec 31, 2023.
- The five-year range for quarterly Cost of Revenue is $34,000 (the quarter ended Mar 31, 2025) to $6.09 million (the quarter ended Dec 31, 2024).
- Year-over-year, Cost of Revenue increased in 1 of the last six quarters, with an average decline of 36.2%.
- Business Quant data shows BLRX's Cost of Revenue at $95,000 (quarter ended Mar 31, 2026), $40,000 (quarter ended Dec 31, 2025) and $84,000 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | BioLineRx | 9.01 Mn | -64.66 Mn | 235,000.00 | 59,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59,000.00 |
| Mar 31, 2026 | 95,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Sep 30, 2025 | 84,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 6.09 Mn |
| Sep 30, 2024 | 822,000.00 |
| Jun 30, 2024 | 897,000.00 |
| Mar 31, 2024 | 1.46 Mn |
| Sep 30, 2010 | 6.74 Mn |
API Access
BioLineRx Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();